 TRASYLOL DOUBLES THE RISK OF KIDNEY FAILURE
Trasylol (aprotinin) has been shown to double the risk of kidney failure, as well as cause heart attacks and stroke. The drug, made by Bayer, has also been linked to degenerative brain diseases known as encephalopathy. These findings were recently published in a January 26, 2006 article in the New England Journal of Medicine .
The U.S. Food and Drug Administration issued a public health advisory on February 8, 2006, in which they admitted they are currently evaluating the safety of Trasylol.
Despite the extensive evidence from these studies, which included 4,374 patients, Bayer maintains that there is no link between the use of Trasylol and increased rate of kidney failure, heart attacks, strokes, or encephalopathy.
Trasylol is a blot clotting drug prescribed for patients who have undergone heart bypass surgery. It is an injection and is used to prevent blood loss and the need for a blood transfusion in patients undergoing heart surgery.
Patients who have used Trasylol should make sure that a physician is monitoring their condition closely for any signs of toxicity or other side effects.
Kidney failure is marked by:
- high blood pressure
- back pain
- frequent urination and blood in the urine
Symptoms of encephalopathy include confusion, decreased responsiveness, speech impairment, and muscle stiffness.
If a patient has suffered from kidney damage, they may require dialysis. Ther are two types of kidney dialysis- hemodialysis and peritoneal dialysis. There are safer alternatives and the drug should be avoided except in unusual circumstances.
If
you or a member of your family has taken Trasylol, then you may qualify for a lawsuit
claim. Thousands of people have already
filed claims.
In
America today there are thousands of mass lawsuits and billions of dollars in unclaimed
monies available for victims. If you have
been wronged by a major corporation, you may
be entitled to compensation for treatments
and pain and suffering. |